Anticipation and Expectations of a Medical OEM Design Control Audit
View: 316
Website https://compliance2go.com/product/?pid=CP2014-361 |
Edit Freely
Category Medical Device
Deadline: October 15, 2014 | Date: October 15, 2014
Venue/Country: Houston, U.S.A
Updated: 2014-10-01 16:36:30 (GMT+9)
Call For Papers - CFP
DESCRIPTIONThis webinar on a Design Control Audit by the FDA and other bodies will provide an understanding of what a medical OEM should anticipate during an audit during a design control audit. All medical device companies that are in need of examining their design control process should be aware of what to expect.Why Should You Attend?The FDA and other authorizing bodies have become more stringent in their examination of medical OEM procedures, process, and data. Many medical industry companies have not completed all their testing and design reviews before commercialising products properly or brought their mature product lines up to current FDA standards and are not in total compliance. This webinar shows the process to be followed for developing a standard procedure to identify what is expected for design control.For example, companies should be compliant to 21 CFR 820, ISO 13485:2003, ISO 14971:2007, etc. Design History Files and validations need to be up to date to meet current standards. The FDA and other authorising bodies expect continuous improvement and risk management to be integrated into the company quality system. Old medical devices need to have a risk assessment for each product and updated validations for product and processes. It should describe the risk acceptance criteria as well as roles and responsibilities of each member on the team.In this webinar, we will discuss practical steps you can follow to make sure your product design control and quality files are ready for an audit. It will also give the attendee guidelines on how to deal with the authorising bodies.Areas Covered in the Seminar:Champion/Multi-functional team approach/responsibilityDealing with the FDA and other authorizing bodiesPhase by phase design process check listDesign input/outputDesign verification/validationDesign changesDesign reviewDesign History File (DHF)Due-diligenceGap analysis ? data gathering for the design history filesRisk assessmentDesign changesPlanning to be preparedWho will benefit:This webinar will provide valuable assistance and give a process to all medical device and regulated companies that need to prepare for an FDA or authorizing bodies audit in the future. The employees who will benefit include:End-users responsible for design control and technical filesR&D and product development Process engineers and managersOperations and plant managementValidation engineersRemediation teamsQA, Regulatory AffairsQC and Corporate AuditorsAll team members who contribute to design history files, clinical, verifications/validations, risk management or technical filesConsultantsProject managersSupplier managementProduct transfer engineersAll Contract Manufacturers working in the medical industryWebinar Includes:Q/A Session with the Expert to ask your questionPDF print only copy of PowerPoint slides90 Minutes Live PresentationCertificate of Attendance
Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.